For research use only. Not for therapeutic Use.
(4S)-Pregabalin amide lactose adduct(Cat No.:C001086)is a molecular complex formed between the amide derivative of (4S)-pregabalin and lactose, typically arising during pharmaceutical formulation or stability studies. Pregabalin, a GABA analog used for neuropathic pain and epilepsy, contains a chiral center at the 4-position, and its amide form improves chemical stability or bioavailability in some applications. When it interacts with lactose—often used as an excipient in solid dosage forms—an adduct may form through hydrogen bonding or Maillard-type reactions. Studying such adducts is crucial for ensuring drug stability, efficacy, and safety in final formulations.
CAS Number | 466678-44-4 |
Synonyms | (4S)-1-(4-O-?-D-Galactopyranosyl-?-D-glucopyranosyl)-4-(2-methylpropyl)-2-pyrrolidinone; (S)-1-((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-4-isobutylpyrrolidin-2-one; |
Molecular Formula | C₂₀H₃₅NO₁₁ |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) |
Appearance | White to Pale Beige Solid |
Storage | 4°C, Hygroscopic |
IUPAC Name | (4S)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-4-(2-methylpropyl)pyrrolidin-2-one |
InChI | InChI=1S/C20H35NO11/c1-8(2)3-9-4-12(24)21(5-9)19-16(28)15(27)18(11(7-23)30-19)32-20-17(29)14(26)13(25)10(6-22)31-20/h8-11,13-20,22-23,25-29H,3-7H2,1-2H3/t9-,10+,11+,13-,14-,15+,16+,17+,18+,19+,20-/m0/s1 |
InChIKey | BSKMCHXCKWARJQ-PZXPMIFTSA-N |
SMILES | CC(C)C[C@H]1CC(=O)N(C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O |
Reference | Lovdahl, M.J., et al.: J. Pharma. Biomed. Anal., 28, 917 (2002); |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |